This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2491) Substance Abuse (428) Opioid and Related Substance Misuse (149) Digital Mental Health Interventions, e-Mental Health and Cyberpsychology (1565) Web-based and Mobile Health Interventions (3357)

Published on in Vol 6, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33073, first published .
Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study

Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study

Patient- and Provider-Reported Experiences of a Mobile Novel Digital Therapeutic in People With Opioid Use Disorder (reSET-O): Feasibility and Acceptability Study

Authors of this article:

Sarah Kawasaki1 Author Orcid Image ;   Sara Mills-Huffnagle1 Author Orcid Image ;   Nicole Aydinoglo2 Author Orcid Image ;   Halley Maxin1 Author Orcid Image ;   Edward Nunes2 Author Orcid Image
Article Authors Cited by (12) Tweetations (2) Metrics

Journals

  1. Xiong X, Braun S, Stitzer M, Luderer H, Shafai G, Hare B, Stevenson M, Maricich Y. Evaluation of real‐world outcomes associated with use of a prescription digital therapeutic to treat substance use disorders. The American Journal on Addictions 2023;32(1):24 View
  2. Richterman A, Ghadimi F, Teitelman A, Moore K, Acri T, North H, Lopez K, Ou V, Van Pelt A, Momplaisir F. Acceptability and Feasibility of a Mobile Phone Application to Support HIV Pre-exposure Prophylaxis Among Women with Opioid Use Disorder. AIDS and Behavior 2023;27(10):3460 View
  3. Suzuki J, Loguidice F, Prostko S, Szpak V, Sharma S, Vercollone L, Garner C, Ahern D. Digitally Assisted Peer Recovery Coach to Facilitate Linkage to Outpatient Treatment Following Inpatient Alcohol Withdrawal Treatment: Proof-of-Concept Pilot Study. JMIR Formative Research 2023;7:e43304 View
  4. Liu T, Zhan Y, Chen S, Zhang W, Jia J. Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with chronic heart failure: model development and data analysis. Cost Effectiveness and Resource Allocation 2023;21(1) View
  5. Alexander K, Sanjuan P, Terplan M. The Use of Ecological Momentary Assessment Methods with People Receiving Medication for Opioid Use Disorder: A Systematic Review. Current Addiction Reports 2023;10(3):366 View
  6. Liu T, Tang Z, Cai C, Wu N, Jia J, Yang G, Zhang W. Cost-effectiveness analysis of digital therapeutics for home-based cardiac rehabilitation for patients with atrial fibrillation after catheter ablation. DIGITAL HEALTH 2023;9 View
  7. Sawyer-Morris G, Wilde J, Molfenter T, Taxman F. Use of Digital Health and Digital Therapeutics to Treat SUD in Criminal Justice Settings: a Review. Current Addiction Reports 2023;11(1):149 View
  8. Biskupiak Z, Ha V, Rohaj A, Bulaj G. Digital Therapeutics for Improving Effectiveness of Pharmaceutical Drugs and Biological Products: Preclinical and Clinical Studies Supporting Development of Drug + Digital Combination Therapies for Chronic Diseases. Journal of Clinical Medicine 2024;13(2):403 View
  9. Stidham, BA J, Jon-Emefieh, BA C, Carrano, PhD J, Wenzel, PhD K, Fishman, MD M. Characteristics of mHealth therapy app engagement by young adults with OUD. Journal of Addictive Diseases 2024:1 View
  10. Regnier S, Mullis L, Nugent A, Marcum T, Turner M, Schulz J, Lile J, Shellenberg T, Stoops W. Adapting a Functional Assessment of Cigarette Smoking for People with Intellectual and Developmental Disabilities. Behavior Analysis in Practice 2024 View
  11. Garland E, Recasens M, Taple B, Donaldson G, Weisberg R. Virtual reality-based Mindfulness-Oriented Recovery Enhancement (MORE-VR) as an adjunct to medications for opioid use disorder: a Phase 1 trial. Annals of Medicine 2024;56(1) View

Books/Policy Documents

  1. Cabrera D, Khan M. From Stigma to Support. View